58 results on '"Barletta G"'
Search Results
2. PO-1269 Cardiological monitoring and safety of 5-fraction whole breast irradiation: SAFE-FORWARD study
3. 66P Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
4. Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
5. Defect-Driven topology optimization for fatigue design of additive manufacturing structures: Application on a real industrial aerospace component
6. Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
7. EP08.01-088 Direct Acting Antivirals (DAA) and Immune Checkpoint Inhibitors (ICIs) Therapy in Patients with Lung Cancer and Hepatitis C
8. 1043P Clinical predictors of benefit from pembrolizumab (pembro) or pembro-chemotherapy (CHT) in advanced non-small cell lung cancer (NSCLC)
9. EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)
10. OC-0935 Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
11. Electrical overstress effect characterization on Power MOS Trenchfet and correlation with time dependent dielectric breakdown
12. Pre-specified interim analysis of the SAFE trial (NCT2236806): A 4-arm randomized, double-blind, controlled study evaluating the efficacy and safety of cardiotoxicity prevention in non-metastatic breast cancer patients treated with anthracyclines with or without trastuzumab
13. P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial)
14. P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab
15. P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit from Nivolumab in Advanced Non-Small Cell Lung Cancer
16. P2.03-28 Whole Exome Sequencing to Discover Lung Tumor Predisposition in Women with Previous Breast Cancer
17. Lung cancer predisposition in women with previous breast cancer identified by whole exome sequencing
18. Investigation of degradation mechanisms in low-voltage p-channel power MOSFETs under High Temperature Gate Bias stress
19. P.05.3 OBSTRUCTIVE DEFECATION DIAGNOSIS: HIGH RESOLUTION AND 3D ANORECTAL MANOMETRY (HR-3D ARM) VS DYNAMIC-MAGNETIC RESONANCE IMAGING (D-MRI)
20. Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation
21. P1.07-023 The Correlation Between B7-H4 Expression and Survival of Non-Small Cell Lung Cancer Patients Treated with Nivolumab
22. Overall survival (OS) of selected patients (Pts) with non-small cell lung cancer (NSCLC) receiving nivolumab beyond progression
23. Study of gate leakage mechanism in advanced charge-coupled MOSFET (CC-MOSFET) technology
24. Upright posture increases the strength of baroreflex coupling between heart period and blood pressure in human subjects
25. Correlation between circulating tumor biomarkers and positron-emission tomography in advanced non-small cell lung cancer
26. Clinical applications of a next-generation sequencing panel in non-small cell lung cancer
27. In vitro and in vivo antitumor efficacy of the sequentially combined vinorelbine and gefitinib in Non-Small Cell Lung Cancer cell lines
28. 3123 Correlation between circulating tumor biomarkers and positronemission tomography in advanced non-small cell lung cancer
29. Echocardiographic findings in patients with eating disorders: A case–control study
30. P0100 : QT adaptation during exercise in liver cirrhosis: Adjunctive signs of cirrhotic cardiomyopathy
31. A new integrated instrumental approach to autonomic nervous system assessment
32. Serum Mass-Spectrometry Test in First Line Advanced Nsclc Patients Treated with Standard Chemotherapy Regimens
33. A Novel Prognostic Microrna Signature in Malignant Pleural Mesothelioma
34. Ribonucleotide Reductase Subunit 2 (RRM2) Predicts Shorter Survival in Resected Stage I-III Non-Small Cell Lung Cancer (NSCLC) Patients
35. The relevance of stable disease (SD) as a surrogate end-point in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib (E) as the second/third line
36. Switching on the deep brain stimulation: Effects on cardiovascular regulation and respiration
37. 1446 POSTER Evaluation of CTL Antigen 4 (CTLA-4) Expression as Prognostic Factor in Non-small Cell Lung Cancer (NSCLC)
38. Spectral analysis of heart rate variability reveals an enhanced sympathetic activity in narcolepsy with cataplexy
39. P1.21 Analysis of heart rate variability demonstrates cardiac hypersympathetic tone at rest in narcolepsy with cataplexy
40. Corrigendum to “Central and cardiovascular responses to emotional stimuli are normal in non-phobic subjects with Reflex Syncope”
41. Central and cardiovascular responses to emotional stimuli are normal in non-phobic subjects with Reflex Syncope
42. Applications of two critical point results for non-differentiable indefinite functionals
43. Altered autonomic modulation of cerebral blod flow in cirrhosis
44. Hemodynamic, renal and endocrine effects of nitric oxide synthase inhibition in compensated cirrhosis
45. The clinical impact of dynamic intraventricular obstruction during dobutamine stress echocardiography
46. Preliminary test of a large electrochromic window
47. Cardiac and renal response to posture in cirrhotics with and without essential hypertension
48. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis
49. Acute hypotensive effect of metoclopramide in Autonomic Failure (AF)
50. Atropine test in patients with Autonomic Failure (AF)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.